Works matching DE "CANCER immunotherapy"

Results: 2517

Combinatorial immunotherapy with checkpoint blockers solves the problem of metastatic melanoma—An exclamation sign with a question mark.

Published in:

OncoImmunology, 2015, v. 4, n. 7, p. N.PAG, doi. 10.1080/2162402X.2015.1058037

By:

Kroemer, Guido;
Galluzzi, Lorenzo

Publication type:

Article

Prolonged progression-free survival after consolidating second or later remissions of neuroblastoma with Anti-G D2 immunotherapy and isotretinoin: a prospective Phase II study.

Published in:

OncoImmunology, 2015, v. 4, n. 7, p. N.PAG, doi. 10.1080/2162402X.2015.1016704

By:

Kushner, Brian H;
Ostrovnaya, Irina;
Cheung, Irene Y;
Kuk, Deborah;
Kramer, Kim;
Modak, Shakeel;
Yataghene, Karima;
Cheung, Nai-Kong V

Publication type:

Article

Reprogramming the tumor microenvironment: tumor-induced immunosuppressive factors paralyze T cells.

Published in:

OncoImmunology, 2015, v. 4, n. 7, p. N.PAG, doi. 10.1080/2162402X.2015.1016700

By:

Wu, Annie A;
Drake, Virginia;
Huang, Huai-Shiuan;
Chiu, ShihChi;
Zheng, Lei

Publication type:

Article

“ In situ ” vaccination for systemic effects in follicular lymphoma.

Published in:

OncoImmunology, 2015, v. 4, n. 7, p. N.PAG, doi. 10.1080/2162402X.2015.1014773

By:

Kolstad, Arne;
Olweus, Johanna

Publication type:

Article

Cancer-targeted IL-12 controls human rhabdomyosarcoma by senescence induction and myogenic differentiation.

Published in:

OncoImmunology, 2015, v. 4, n. 7, p. N.PAG, doi. 10.1080/2162402X.2015.1014760

By:

Schilbach, Karin;
Alkhaled, Mohammed;
Welker, Christian;
Eckert, Franziska;
Blank, Gregor;
Ziegler, Hendrik;
Sterk, Marco;
Müller, Friederike;
Sonntag, Katja;
Wieder, Thomas;
Braumüller, Heidi;
Schmitt, Julia;
Eyrich, Matthias;
Schleicher, Sabine;
Seitz, Christian;
Erbacher, Annika;
Pichler, Bernd J;
Müller, Hartmut;
Tighe, Robert;
Lim, Annick

Publication type:

Article

Antileukemia T-cell responses in CLL – We don't need no aberration.

Published in:

OncoImmunology, 2015, v. 4, n. 7, p. N.PAG, doi. 10.1080/2162402X.2015.1011527

By:

Kowalewski, Daniel J;
Stevanovic, Stefan;
Rammensee, Hans-Georg;
Stickel, Juliane S

Publication type:

Article

Depletion of regulatory T cells by targeting CC chemokine receptor type 4 with mogamulizumab.

Published in:

OncoImmunology, 2015, v. 4, n. 7, p. N.PAG, doi. 10.1080/2162402X.2015.1011524

By:

Ni, Xiao;
Langridge, Timothy;
Duvic, Madeleine

Publication type:

Article

Strong spontaneous tumor neoantigen responses induced by a natural human carcinogen.

Published in:

OncoImmunology, 2015, v. 4, n. 7, p. N.PAG, doi. 10.1080/2162402X.2015.1011492

By:

Creaney, Jenette;
Ma, Shaokang;
Sneddon, Sophie A;
Tourigny, Michelle R;
Dick, Ian M;
Leon, Justine S;
Khong, Andrea;
Fisher, Scott A;
Lake, Richard A;
Lesterhuis, W Joost;
Nowak, Anna K;
Leary, Shay;
Watson, Mark W;
Robinson, Bruce W

Publication type:

Article

Kick-starting the cancer-immunity cycle by targeting CD40.

Published in:

OncoImmunology, 2015, v. 4, n. 7, p. N.PAG, doi. 10.1080/2162402X.2015.1011484

By:

Ellmark, P;
Mangsbo, S M;
Furebring, C;
Tötterman, T H;
Norlén, P

Publication type:

Article

Improving clinical benefit for prostate cancer patients through the combination of androgen deprivation and immunotherapy.

Published in:

OncoImmunology, 2015, v. 4, n. 6, p. 0, doi. 10.1080/2162402X.2015.1009303

By:

Kwilas, Anna R;
Gameiro, Sofia R;
Kim, Peter S;
Malamas, Anthony S;
Hodge, James W

Publication type:

Article

CD14 macrophage-like cells as the linchpin of cervical cancer perpetrated immune suppression and early metastatic spread: A new therapeutic lead?

Published in:

OncoImmunology, 2015, v. 4, n. 6, p. 0, doi. 10.1080/2162402X.2015.1009296

By:

Heeren, A Marijne;
Kenter, Gemma G;
Jordanova, Ekaterina S;
de Gruijl, Tanja D

Publication type:

Article

Implications of understanding the signaling, cellular, and cytotoxic mechanisms afforded by afucosylated antibodies.

Published in:

OncoImmunology, 2015, v. 4, n. 6, p. 0, doi. 10.1080/2162402X.2015.1009288

By:

Liu, Scot D;
Lowe, John B

Publication type:

Article

The tumoral and stromal immune microenvironment in malignant pleural mesothelioma: A comprehensive analysis reveals prognostic immune markers.

Published in:

OncoImmunology, 2015, v. 4, n. 6, p. 0, doi. 10.1080/2162402X.2015.1009285

By:

Ujiie, Hideki;
Kadota, Kyuichi;
Nitadori, Jun-ichi;
Aerts, Joachim G;
Woo, Kaitlin M;
Sima, Camelia S;
Travis, William D;
Jones, David R;
Krug, Lee M;
Adusumilli, Prasad S

Publication type:

Article

Interferon-γ-induced activation of JAK1 and JAK2 suppresses tumor cell susceptibility to NK cells through upregulation of PD-L1 expression.

Published in:

OncoImmunology, 2015, v. 4, n. 6, p. 0, doi. 10.1080/2162402X.2015.1008824

By:

Bellucci, Roberto;
Martin, Allison;
Bommarito, Davide;
Wang, Kathy;
Hansen, Steen H;
Freeman, Gordon J;
Ritz, Jerome

Publication type:

Article

Are BiTEs the “missing link” in cancer therapy?

Published in:

OncoImmunology, 2015, v. 4, n. 6, p. 0, doi. 10.1080/2162402X.2015.1008339

By:

Suryadevara, Carter M;
Gedeon, Patrick C;
Sanchez-Perez, Luis;
Verla, Terence;
Alvarez-Breckenridge, Christopher;
Choi, Bryan D;
Fecci, Peter E;
Sampson, John H

Publication type:

Article

γδ T cells and epigenetic drugs: A useful merger in cancer immunotherapy?

Published in:

OncoImmunology, 2015, v. 4, n. 6, p. 0, doi. 10.1080/2162402X.2015.1006088

By:

Bhat, Jaydeep;
Kabelitz, Dieter

Publication type:

Article

Regramming myeloid responses to improve cancer immunotherapy.

Published in:

OncoImmunology, 2015, v. 4, n. 6, p. 0, doi. 10.4161/2162402X.2014.974399

By:

Zhu, Yu;
Hawkins, William G;
DeNardo, David G

Publication type:

Article

Personalized peptide vaccination for advanced colorectal cancer.

Published in:

OncoImmunology, 2015, v. 4, n. 5, p. 0, doi. 10.1080/2162402X.2015.1005512

By:

Sasada, Tetsuro;
Kibe, Shiro;
Akagi, Yoshito;
Itoh, Kyogo

Publication type:

Article

CD20 T cells have a predominantly Tc1 effector memory phenotype and are expanded in the ascites of patients with ovarian cancer.

Published in:

OncoImmunology, 2015, v. 4, n. 4, p. 00, doi. 10.1080/2162402X.2014.999536

By:

de Bruyn, Marco;
Wouters, Maartje C A;
Klip, Harry G;
Nijman, Hans W;
Wiersma, Valerie R;
Samplonius, Douwe F;
Helfrich, Wijnand;
Bremer, Edwin;
Eggleton, Paul

Publication type:

Article

Natural Killer cell control of BRAFV600E mutant melanoma during targeted therapy.

Published in:

OncoImmunology, 2015, v. 4, n. 4, p. 00, doi. 10.1080/2162402X.2014.998119

By:

Ngiow, Shin Foong;
de Andrade, Lucas Ferrari;
Martinet, Ludovic;
Smyth, Mark J

Publication type:

Article

Anti-angiogenic activity of VXM01, an oral T-cell vaccine against VEGF receptor 2, in patients with advanced pancreatic cancer: A randomized, placebo-controlled, phase 1 trial.

Published in:

OncoImmunology, 2015, v. 4, n. 4, p. 00, doi. 10.1080/2162402X.2014.1001217

By:

Schmitz-Winnenthal, Friedrich H;
Weitz, Jürgen;
Ulrich, Alexis;
Buechler, Markus W;
Pianka, Frank;
Klaiber, Ulla;
Diener, Markus;
Leowardi, Christine;
Schimmack, Simon;
Sisic, Leila;
Keller, Anne-Valerie;
Koc, Ruhan;
Knebel, Philipp;
Schmidt, Thomas;
Hohmann, Nicolas;
Mikus, Gerd;
Haefeli, Walter E;
Niethammer, Andreas G;
Breiner, Klaus M;
Friedrich, Tobias

Publication type:

Article

The potential impact of mouse model selection in preclinical evaluation of cancer immunotherapy.

Published in:

2014

By:

Westwood, Jennifer A;
Darcy, Phillip K;
Kershaw, Michael H

Publication type:

Opinion

A novel combinatorial cancer immunotherapy.

Published in:

OncoImmunology, 2014, v. 3, n. 5, p. N.PAG, doi. 10.4161/onci.28440

By:

Nagato, Toshihiro;
Celis, Esteban

Publication type:

Article

Local CTLA4 blockade effectively restrains experimental pancreatic adenocarcinoma growth in vivo.

Published in:

OncoImmunology, 2014, v. 3, n. 1, p. N.PAG, doi. 10.4161/onci.27614

By:

Sandin, Linda C;
Eriksson, Fredrik;
Ellmark, Peter;
Loskog, Angelica SI;
Tötterman, Thomas H;
Mangsbo, Sara M

Publication type:

Article

Implementing combinatorial immunotherapeutic regimens against cancer.

Published in:

OncoImmunology, 2014, v. 3, n. 1, p. N.PAG, doi. 10.4161/onci.27588

By:

Wolf, Dominik;
Heine, Annkristin;
Brossart, Peter

Publication type:

Article

?? T cells for cancer immunotherapy.

Published in:

OncoImmunology, 2014, v. 3, n. 1, p. N.PAG, doi. 10.4161/onci.27572

By:

Fisher, Jonathan PH;
Heuijerjans, Jennifer;
Yan, Mengyong;
Gustafsson, Kenth;
Anderson, John

Publication type:

Article

A novel minigene scaffold for therapeutic cancer vaccines.

Published in:

OncoImmunology, 2014, v. 3, n. 1, p. N.PAG, doi. 10.4161/onci.27529

By:

Aurisicchio, Luigi;
Fridman, Arthur;
Bagchi, Ansuman;
Scarselli, Elisa;
La Monica, Nicola;
Ciliberto, Gennaro

Publication type:

Article

The anticancer effects of HDAC inhibitors require the immune system.

Published in:

OncoImmunology, 2014, v. 3, n. 1, p. N.PAG, doi. 10.4161/onci.27414

By:

West, Alison C;
Smyth, Mark J;
Johnstone, Ricky W

Publication type:

Article

Chemokine-enhanced DNA vaccination in cancer immunotherapy.

Published in:

OncoImmunology, 2013, v. 2, n. 10, p. e26092-1, doi. 10.4161/onci.26092

By:

Igoucheva, Olga;
Jonas, Rebecca;
Alexeev, Vitali

Publication type:

Article

A new role for NFkB in immunosurveillance and its implications for cancer immunotherapy.

Published in:

OncoImmunology, 2013, v. 2, n. 10, p. e25963-1, doi. 10.4161/onci.25963

By:

Beg, Amer A.;
Khan, Tahira;
Antonia, Scott J.

Publication type:

Article

Recruitment of γδ T lymphocytes to tumors.

Published in:

OncoImmunology, 2013, v. 2, n. 8, p. 1, doi. 10.4161/onci.25461

By:

Lança, Telma;
Silva-Santos, Bruno

Publication type:

Article

Could the properties of IL-27 make it an ideal adjuvant for anticancer immunotherapy?

Published in:

OncoImmunology, 2013, v. 2, n. 8, p. 1, doi. 10.4161/onci.25409

By:

Swarbrick, Alexander;
Junankar, Simon R.;
Batten, Marcel

Publication type:

Article

The many flavors of tumor-associated B cells.

Published in:

OncoImmunology, 2013, v. 2, n. 8, p. 1, doi. 10.4161/onci.25237

By:

Marits, Per;
Zirakzadeh, Ali A.;
Sherif, Amir;
Winqvist, Ola

Publication type:

Article

Arming NK cells with enhanced antitumor activity.

Published in:

OncoImmunology, 2013, v. 2, n. 8, p. 1, doi. 10.4161/onci.25220

By:

Oberoi, Pranav;
Wels, Winfried S.

Publication type:

Article

Immunological proiling as a means to invigorate personalized cancer treatment.

Published in:

OncoImmunology, 2013, v. 2, n. 8, p. 1, doi. 10.4161/onci.25236

By:

Hegmans, Joost P. J. J.;
Aerts, Joachim G. J. V.

Publication type:

Article

New immunotherapeutic paradigms for castration-resistant prostate cancer.

Published in:

OncoImmunology, 2013, v. 2, n. 8, p. 1, doi. 10.4161/onci.26084

By:

Galluzzi, Lorenzo

Publication type:

Article

Current trends of anticancer immunochemotherapy.

Published in:

2013

By:

Vacchelli, Erika;
Prada, Nicole;
Kepp, Oliver;
Galluzzi, Lorenzo

Publication type:

Editorial

Immunotherapy of HPV-associated head and neck cancer.

Published in:

OncoImmunology, 2013, v. 2, n. 6, p. e24534-1, doi. 10.4161/onci.24534

By:

Nizard, Mevyn;
Sandoval, Federico;
Badoual, Cecile;
Pere, Helene;
Terme, Magali;
Hans, Stephane;
Benhamouda, Nadine;
Granier, Clemence;
Brasnu, Daniel;
Tartour, Eric

Publication type:

Article

IL-21 in cancer immunotherapy.

Published in:

OncoImmunology, 2013, v. 2, n. 6, p. e24522-1, doi. 10.4161/onci.24522

By:

Santegoets, Saskia J. A. M.;
Turksma, Annelies W.;
Powell Jr., Daniel J.;
Hooijberg, Erik;
de Gruijl, Tanja D.

Publication type:

Article

Cancer immunotherapy with exosomes requires B-cell activation.

Published in:

OncoImmunology, 2013, v. 2, n. 6, p. e24533-1, doi. 10.4161/onci.24533

By:

Näslund, Tanja I.;
Gehrmann, Ulf;
Gabrielsson, Susanne

Publication type:

Article

The immunological profile of tumor-bearing animals determines the outcome of cancer immunotherapy.

Published in:

OncoImmunology, 2013, v. 2, n. 6, p. e24499-1, doi. 10.4161/onci.24499

By:

Quetglas, José I.;
Hervas-Stubbs, Sandra;
Smerdou, Cristian

Publication type:

Article

Importance of helper T-cell activation in dendritic cell-based anticancer immunotherapy.

Published in:

OncoImmunology, 2013, v. 2, n. 6, p. e24440-1, doi. 10.4161/onci.24440

By:

Schreibelt, Gerty;
Bol, Kalijn F.;
Aarntzen, Erik H. J. G.;
Gerritsen, Winald R.;
Punt, Cornelis J. A.;
Figdor, Carl G.;
de Vries, I. Jolanda M.

Publication type:

Article

Engineering Grp170-based immune modulators for cancer immunotherapy.

Published in:

OncoImmunology, 2013, v. 2, n. 6, p. e24385-1, doi. 10.4161/onci.24385

By:

Xiaofei Yu;
Xiang-Yang Wang

Publication type:

Article

Cancer immunotherapy turns viral.

Published in:

2013

By:

Galluzzi, Lorenzo;
Lugli, Enrico

Publication type:

Editorial

Myeloid derived suppressor cells.

Published in:

OncoImmunology, 2013, v. 2, n. 4, p. e24117-1, doi. 10.4161/onci.24117

By:

Waldron, Todd J.;
Quatromoni, Jon G.;
Karakasheva, Tatiana A.;
Singhal, Sunil;
Rustgi, Anil K.

Publication type:

Article

Toward the next generation of NK cell-based adoptive cancer immunotherapy.

Published in:

OncoImmunology, 2013, v. 2, n. 4, p. e23811-1, doi. 10.4161/onci.23811

By:

Ni, Jing;
Miller, Matthias;
Stojanovic, Ana;
Cerwenka, Adelheid

Publication type:

Article

Cancer vaccines.

Published in:

OncoImmunology, 2013, v. 2, n. 3, p. e23403-1, doi. 10.4161/onci.23403

By:

Yaddanapudi, Kavitha;
Mitchell, Robert A.;
Eaton, John W.

Publication type:

Article

Unique pulmonary antigen presentation may call for an alternative approach toward lung cancer immunotherapy.

Published in:

2013

By:

Stephanie Chang;
Xue Lin;
Higashikubo, Ryuji;
Toth, Kelsey;
Gelman, Andrew E.;
Kreisel, Daniel;
Krupnick, Alexander S.

Publication type:

Opinion

Rejuvenated T cells attack old tumors.

Published in:

OncoImmunology, 2013, v. 2, n. 2, p. e24103-1, doi. 10.4161/onci.24103

By:

Galluzzi, Lorenzo;
Lugli, Enrico

Publication type:

Article

12th International Dendritic Cell Symposium, October 7-11, 2012; Daegu, Korea.

Published in:

2013

By:

Heung Kyu Lee;
Yong-Soo Bae

Publication type:

Proceeding